DAVOS 2016: Final Declaration by the Pharmaceutical, Biotechnology and Diagnostics Industries on Combating Antimicrobial Resistance published

Blueberry Therapeutics Ltd are amongst 80 co-signatories on a declaration at the World Economic Forum in Davos committing to working together to solve the growing issue of antimicrobial drug resistance and calling for governments to improve financial incentives and investment to support this effort.

The detail of the text can be found here: 



2016-05-13T10:40:17+00:00 January 22nd, 2016|